Comprehensive analysis of microRNA expression profile in malignant glioma tissues

Molecular Oncology

Volumn 9, Issue 7, 2015, Pages 1324-1340

  Piwecka, Monika ^a   Rolle, Katarzyna ^a   Belter, Agnieszka ^a   Barciszewska, Anna Maria ^b   Zywicki, Marek ^c   Michalak, Marcin ^d   Nowak, Stanisław ^b   Naskret Barciszewska, Mirosława Z ^a   Barciszewski, Jan ^a  

^a INSTITUTE OF BIOORGANIC CHEMISTRY   (Poland)

^b POZNAN UNIVERSITY OF MEDICAL SCIENCES   (Poland)

^c ADAM MICKIEWICZ UNIVERSITY   (Poland)

^d INSTITUTE OF DENDROLOGY   (Poland)

Author keywords

Brain tumors; Glioblastoma; Gliomas; Meta Analysis; MicroRNA; MiRNA profiling

Indexed keywords

BIOLOGICAL MARKER; MICRORNA;

ARTICLE; CANCER TISSUE; CONTROLLED STUDY; GLIOBLASTOMA; HUMAN; HUMAN TISSUE; META ANALYSIS; PRIORITY JOURNAL; RNA ANALYSIS; RNA ISOLATION; RNA SEQUENCE; SEQUENCE ANALYSIS; GENE EXPRESSION PROFILING; GENETICS; HIGH THROUGHPUT SEQUENCING; METABOLISM;

BIOMARKERS; GENE EXPRESSION PROFILING; GLIOBLASTOMA; HIGH-THROUGHPUT NUCLEOTIDE SEQUENCING; HUMANS; MICRORNAS;

EID: 84930930618     PISSN: 15747891     EISSN: 18780261     Source Type: Journal    
DOI: 10.1016/j.molonc.2015.03.007     Document Type: Article

References (74)

1. Bader A.G. miR-34-a microRNA replacement therapy is headed to the clinic. Front. Genet. 2012, 3:120.
2. Birks D.K., Barton V.N., Donson A.M., Handler M.H., Vibhakar R., Foreman N.K. Survey of MicroRNA expression in pediatric brain tumors. Pediatr. Blood Cancer 2011, 56:211-216.
3. Bonavia R., Inda M.M., Cavenee W.K., Furnari F.B. Heterogeneity maintenance in glioblastoma: a social network. Cancer Res. 2011, 71:4055-4060.
4. Brennan C.W., Verhaak R.G., McKenna A., Campos B., Noushmehr H., Salama S.R., Zheng S., Chakravarty D., Sanborn J.Z., Berman S.H., Beroukhim R., Bernard B., Wu C.J., Genovese G., Shmulevich I., Barnholtz-Sloan J., Zou L., Vegesna R., Shukla S.A., Ciriello G., Yung W.K., Zhang W., Sougnez C., Mikkelsen T., Aldape K., Bigner D.D., Van Meir E.G., Prados M., Sloan A., Black K.L., Eschbacher J., Finocchiaro G., Friedman W., Andrews D.W., Guha A., Iacocca M., O'Neill B.P., Foltz G., Myers J., Weisenberger D.J., Penny R., Kucherlapati R., Perou C.M., Hayes D.N., Gibbs R., Marra M., Mills G.B., Lander E., Spellman P., Wilson R., Sander C., Weinstein J., Meyerson M., Gabriel S., Laird P.W., Haussler D., Getz G., Chin L. The somatic genomic landscape of glioblastoma. Cell 2013, 155:462-477.
5. Cheng L., Bao S., Rich J.N. Potential therapeutic implications of cancer stem cells in glioblastoma. Biochem. Pharmacol. 2010, 80:654-665.
6. Ciafre S.A., Galardi S., Mangiola A., Ferracin M., Liu C.G., Sabatino G., Negrini M., Maira G., Croce C.M., Farace M.G. Extensive modulation of a set of microRNAs in primary glioblastoma. Biochem. Biophys. Res. Commun. 2005, 334:1351-1358.
7. Conti A., Aguennouz M., La Torre D., Tomasello C., Cardali S., Angileri F.F., Maio F., Cama A., Germano A., Vita G., Tomasello F. miR-21 and 221 upregulation and miR-181b downregulation in human grade II-IV astrocytic tumors. J. Neurooncol. 2009, 93:325-332.
8. David M., Dzamba M., Lister D., Ilie L., Brudno M. SHRiMP2: sensitive yet practical SHort Read Mapping. Bioinformatics 2011, 27:1011-1012.
9. Di Leva G., Garofalo M., Croce C.M. MicroRNAs in cancer. Annu. Rev. Pathol. 2014, 9:287-314.
10. Dong H., Siu H., Luo L., Fang X., Jin L., Xiong M. Investigation gene and microRNA expression in glioblastoma. BMC Genomics 2010, 11(Suppl. 3):S16.
11. D'Urso P.I., D'Urso O.F., Storelli C., Mallardo M., Gianfreda C.D., Montinaro A., Cimmino A., Pietro C., Marsigliante S. miR-155 is up-regulated in primary and secondary glioblastoma and promotes tumour growth by inhibiting GABA receptors. Int. J. Oncol. 2012, 41:228-234.
12. Fang Z., Rajewsky N. The impact of miRNA target sites in coding sequences and in 3'UTRs. PLoS One 2011, 6:e18067.
13. Faraoni I., Antonetti F.R., Cardone J., Bonmassar E. miR-155 gene: a typical multifunctional microRNA. Biochim. Biophys. Acta 2009, 1792:497-505.
14. Friedlander M.R., Mackowiak S.D., Li N., Chen W., Rajewsky N. miRDeep2 accurately identifies known and hundreds of novel microRNA genes in seven animal clades. Nucleic Acids Res. 2012, 40:37-52.
15. Friedman R.C., Farh K.K., Burge C.B., Bartel D.P. Most mammalian mRNAs are conserved targets of microRNAs. Genome Res. 2009, 19:92-105.
16. Furnari F.B., Fenton T., Bachoo R.M., Mukasa A., Stommel J.M., Stegh A., Hahn W.C., Ligon K.L., Louis D.N., Brennan C., Chin L., DePinho R.A., Cavenee W.K. Malignant astrocytic glioma: genetics, biology, and paths to treatment. Genes Dev. 2007, 21:2683-2710.
17. Godlewski J., Nowicki M.O., Bronisz A., Williams S., Otsuki A., Nuovo G., Raychaudhury A., Newton H.B., Chiocca E.A., Lawler S. Targeting of the Bmi-1 oncogene/stem cell renewal factor by microRNA-128 inhibits glioma proliferation and self-renewal. Cancer Res. 2008, 68:9125-9130.
18. Gu W., Wang X., Zhai C., Zhou T., Xie X. Biological basis of miRNA action when their targets are located in human protein coding region. PLoS One 2013, 8:e63403.
19. Guessous F., Zhang Y., Kofman A., Catania A., Li Y., Schiff D., Purow B., Abounader R. microRNA-34a is tumor suppressive in brain tumors and glioma stem cells. Cell Cycle 2010, 9:1031-1036.
20. Hu H.Y., Guo S., Xi J., Yan Z., Fu N., Zhang X., Menzel C., Liang H., Yang H., Zhao M., Zeng R., Chen W., Paabo S., Khaitovich P. MicroRNA expression and regulation in human, chimpanzee, and macaque brains. PLoS Genet. 2011, 7:e1002327.
21. Hua D., Mo F., Ding D., Li L., Han X., Zhao N., Foltz G., Lin B., Lan Q., Huang Q. A catalogue of glioblastoma and brain MicroRNAs identified by deep sequencing. OMICS 2012, 16:690-699.
22. Huse J.T., Brennan C., Hambardzumyan D., Wee B., Pena J., Rouhanifard S.H., Sohn-Lee C., le Sage C., Agami R., Tuschl T., Holland E.C. The PTEN-regulating microRNA miR-26a is amplified in high-grade glioma and facilitates gliomagenesis in vivo. Genes Dev. 2009, 23:1327-1337.
23. Iorio M.V., Croce C.M. MicroRNA dysregulation in cancer: diagnostics, monitoring and therapeutics. A comprehensive review. EMBO Mol. Med. 2012, 4:143-159.
24. Jiang L., Lin C., Song L., Wu J., Chen B., Ying Z., Fang L., Yan X., He M., Li J., Li M. MicroRNA-30e* promotes human glioma cell invasiveness in an orthotopic xenotransplantation model by disrupting the NF-kappaB/IkappaBalpha negative feedback loop. J. Clin. Invest. 2012, 122:33-47.
25. Jiang L., Mao P., Song L., Wu J., Huang J., Lin C., Yuan J., Qu L., Cheng S.Y., Li J. miR-182 as a prognostic marker for glioma progression and patient survival. Am. J. Pathol. 2010, 177:29-38.
26. Jiang Q., Wang Y., Hao Y., Juan L., Teng M., Zhang X., Li M., Wang G., Liu Y. miR2Disease: a manually curated database for microRNA deregulation in human disease. Nucleic Acids Res. 2009, 37:D98-D104.
27. Kapsimali M., Kloosterman W.P., de Bruijn E., Rosa F., Plasterk R.H., Wilson S.W. MicroRNAs show a wide diversity of expression profiles in the developing and mature central nervous system. Genome Biol. 2007, 8:R173.
28. Karsy M., Arslan E., Moy F. Current progress on understanding MicroRNAs in glioblastoma multiforme. Genes Cancer 2012, 3:3-15.
29. Kim T.M., Huang W., Park R., Park P.J., Johnson M.D. A developmental taxonomy of glioblastoma defined and maintained by MicroRNAs. Cancer Res. 2011, 71:3387-3399.
30. Lages E., Guttin A., El Atifi M., Ramus C., Ipas H., Dupre I., Rolland D., Salon C., Godfraind C., deFraipont F., Dhobb M., Pelletier L., Wion D., Gay E., Berger F., Issartel J.P. MicroRNA and target protein patterns reveal physiopathological features of glioma subtypes. PLoS One 2011, 6:e20600.
31. Lang M.F., Yang S., Zhao C., Sun G., Murai K., Wu X., Wang J., Gao H., Brown C.E., Liu X., Zhou J., Peng L., Rossi J.J., Shi Y. Genome-wide profiling identified a set of miRNAs that are differentially expressed in glioblastoma stem cells and normal neural stem cells. PLoS One 2012, 7:e36248.
32. Lavon I., Zrihan D., Granit A., Einstein O., Fainstein N., Cohen M.A., Zelikovitch B., Shoshan Y., Spektor S., Reubinoff B.E., Felig Y., Gerlitz O., Ben-Hur T., Smith Y., Siegal T. Gliomas display a microRNA expression profile reminiscent of neural precursor cells. Neuro Oncol. 2010, 12:422-433.
33. Lee H., Kim K.R., Cho N.H., Hong S.R., Jeong H., Kwon S.Y., Park K.H., An H.J., Kim T.H., Kim I., Yoon H.K., Suh K.S., Min K.O., Choi H.J., Park J.Y., Yoo C.W., Lee Y.S., Lee H.J., Lee W.S., Park C.S., Lee Y. MicroRNA expression profiling and Notch1 and Notch2 expression in minimal deviation adenocarcinoma of uterine cervix. World J. Surg. Oncol. 2014, 12:334.
34. Li W.B., Ma M.W., Dong L.J., Wang F., Chen L.X., Li X.R. MicroRNA-34a targets notch1 and inhibits cell proliferation in glioblastoma multiforme. Cancer Biol. Ther. 2011, 12:477-483.
35. Li Y., Guessous F., Zhang Y., Dipierro C., Kefas B., Johnson E., Marcinkiewicz L., Jiang J., Yang Y., Schmittgen T.D., Lopes B., Schiff D., Purow B., Abounader R. MicroRNA-34a inhibits glioblastoma growth by targeting multiple oncogenes. Cancer Res. 2009, 69:7569-7576.
36. Lopez J.P., Lim R., Cruceanu C., Crapper L., Fasano C., Labonte B., Maussion G., Yang J.P., Yerko V., Vigneault E., El Mestikawy S., Mechawar N., Pavlidis P., Turecki G. miR-1202 is a primate-specific and brain-enriched microRNA involved in major depression and antidepressant treatment. Nat. Med. 2014, 20:764-768.
37. Luan S., Sun L., Huang F. MicroRNA-34a: a novel tumor suppressor in p53-mutant glioma cell line U251. Arch. Med. Res. 2010, 41:67-74.
38. Malzkorn B., Wolter M., Liesenberg F., Grzendowski M., Stuhler K., Meyer H.E., Reifenberger G. Identification and functional characterization of microRNAs involved in the malignant progression of gliomas. Brain Pathol. 2010, 20:539-550.
39. Marino A.L., Evangelista A.F., Vieira R.A., Macedo T., Kerr L.M., Abrahao-Machado L.F., Longatto-Filho A., Silveira H.C., Marques M.M. MicroRNA expression as risk biomarker of breast cancer metastasis: a pilot retrospective case-cohort study. BMC Cancer 2014, 14:739.
40. Mizoguchi M., Guan Y., Yoshimoto K., Hata N., Amano T., Nakamizo A., Sasaki T. MicroRNAs in human malignant gliomas. J. Oncol. 2012, 2012:732874.
41. Mogilyansky E., Rigoutsos I. The miR-17/92 cluster: a comprehensive update on its genomics, genetics, functions and increasingly important and numerous roles in health and disease. Cell Death Differ. 2013, 20:1603-1614.
42. Moller H.G., Rasmussen A.P., Andersen H.H., Johnsen K.B., Henriksen M., Duroux M. A systematic review of microRNA in glioblastoma multiforme: micro-modulators in the mesenchymal mode of migration and invasion. Mol. Neurobiol. 2013, 47:131-144.
43. Moreau M.P., Bruse S.E., Jornsten R., Liu Y., Brzustowicz L.M. Chronological changes in microRNA expression in the developing human brain. PLoS One 2013, 8:e60480.
44. Nikaki A., Piperi C., Papavassiliou A.G. Role of microRNAs in gliomagenesis: targeting miRNAs in glioblastoma multiforme therapy. Expert Opin. Investig. Drugs 2012, 21:1475-1488.
45. Pang Y., Young C.Y., Yuan H. MicroRNAs and prostate cancer. Acta Biochim. Biophys. Sin. (Shanghai) 2010, 42:363-369.
46. Patel D., Boufraqech M., Jain M., Zhang L., He M., Gesuwan K., Gulati N., Nilubol N., Fojo T., Kebebew E. MiR-34a and miR-483-5p are candidate serum biomarkers for adrenocortical tumors. Surgery 2013, 154:1224-1228. discussion 1229.
47. Poliseno L., Salmena L., Riccardi L., Fornari A., Song M.S., Hobbs R.M., Sportoletti P., Varmeh S., Egia A., Fedele G., Rameh L., Loda M., Pandolfi P.P. Identification of the miR-106b~25 microRNA cluster as a proto-oncogenic PTEN-targeting intron that cooperates with its host gene MCM7 in transformation. Sci. Signal 2010, 3:ra29.
48. Purow B. The elephant in the room: do microRNA-based therapies have a realistic chance of succeeding for brain tumors such as glioblastoma?. J. Neurooncol. 2011, 103:429-436.
49. Purow B., Schiff D. Advances in the genetics of glioblastoma: are we reaching critical mass?. Nat. Rev. Neurol. 2009, 5:419-426.
50. Qu X., Zhao M., Wu S., Yu W., Xu J., Li J., Chen L. Circulating microRNA 483-5p as a novel biomarker for diagnosis survival prediction in multiple myeloma. Med. Oncol. 2014, 31:219.
51. Rao S.A., Santosh V., Somasundaram K. Genome-wide expression profiling identifies deregulated miRNAs in malignant astrocytoma. Mod. Pathol. 2010, 23:1404-1417.
52. Sasayama T., Nishihara M., Kondoh T., Hosoda K., Kohmura E. MicroRNA-10b is overexpressed in malignant glioma and associated with tumor invasive factors, uPAR and RhoC. Int. J. Cancer 2009, 125:1407-1413.
53. Schonberg D.L., Bao S., Rich J.N. Genomics informs glioblastoma biology. Nat. Genet. 2013, 45:1105-1107.
54. Setty M., Helmy K., Khan A.A., Silber J., Arvey A., Neezen F., Agius P., Huse J.T., Holland E.C., Leslie C.S. Inferring transcriptional and microRNA-mediated regulatory programs in glioblastoma. Mol. Syst. Biol. 2012, 8:605.
55. Shao N.Y., Hu H.Y., Yan Z., Xu Y., Hu H., Menzel C., Li N., Chen W., Khaitovich P. Comprehensive survey of human brain microRNA by deep sequencing. BMC Genomics 2010, 11:409.
56. Shen J., Wang A., Wang Q., Gurvich I., Siegel A.B., Remotti H., Santella R.M. Exploration of genome-wide circulating microRNA in hepatocellular carcinoma: MiR-483-5p as a potential biomarker. Cancer Epidemiol. Biomarkers Prev. 2013, 22:2364-2373.
57. Silber J., Lim D.A., Petritsch C., Persson A.I., Maunakea A.K., Yu M., Vandenberg S.R., Ginzinger D.G., James C.D., Costello J.F., Bergers G., Weiss W.A., Alvarez-Buylla A., Hodgson J.G. miR-124 and miR-137 inhibit proliferation of glioblastoma multiforme cells and induce differentiation of brain tumor stem cells. BMC Med. 2008, 6:14.
58. Skalsky R.L., Cullen B.R. Reduced expression of brain-enriched microRNAs in glioblastomas permits targeted regulation of a cell death gene. PLoS One 2011, 6:e24248.
59. Slaby O., Lakomy R., Fadrus P., Hrstka R., Kren L., Lzicarova E., Smrcka M., Svoboda M., Dolezalova H., Novakova J., Valik D., Vyzula R., Michalek J. MicroRNA-181 family predicts response to concomitant chemoradiotherapy with temozolomide in glioblastoma patients. Neoplasma 2010, 57:264-269.
60. Srinivasan S., Patric I.R., Somasundaram K. A ten-microRNA expression signature predicts survival in glioblastoma. PLoS One 2011, 6:e17438.
61. Stupp R., Mason W.P., van den Bent M.J., Weller M., Fisher B., Taphoorn M.J., Belanger K., Brandes A.A., Marosi C., Bogdahn U., Curschmann J., Janzer R.C., Ludwin S.K., Gorlia T., Allgeier A., Lacombe D., Cairncross J.G., Eisenhauer E., Mirimanoff R.O. Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N. Engl. J. Med. 2005, 352:987-996.
62. Sun H.B., Chen X., Ji H., Wu T., Lu H.W., Zhang Y., Li H., Li Y.M. miR494 is an independent prognostic factor and promotes cell migration and invasion in colorectal cancer by directly targeting PTEN. Int. J. Oncol. 2014, 45:2486-2494.
63. Tang W., Duan J., Zhang J.G., Wang Y.P. Subtyping glioblastoma by combining miRNA and mRNA expression data using compressed sensing-based approach. EURASIP J. Bioinform. Syst. Biol. 2013, 2013:2.
64. Verhaak R.G., Hoadley K.A., Purdom E., Wang V., Qi Y., Wilkerson M.D., Miller C.R., Ding L., Golub T., Mesirov J.P., Alexe G., Lawrence M., O'Kelly M., Tamayo P., Weir B.A., Gabriel S., Winckler W., Gupta S., Jakkula L., Feiler H.S., Hodgson J.G., James C.D., Sarkaria J.N., Brennan C., Kahn A., Spellman P.T., Wilson R.K., Speed T.P., Gray J.W., Meyerson M., Getz G., Perou C.M., Hayes D.N. Integrated genomic analysis identifies clinically relevant subtypes of glioblastoma characterized by abnormalities in PDGFRA, IDH1, EGFR, and NF1. Cancer Cell 2010, 17:98-110.
65. Visani M., de Biase D., Marucci G., Cerasoli S., Nigrisoli E., Bacchi Reggiani M.L., Albani F., Baruzzi A., Pession A. Expression of 19 microRNAs in glioblastoma and comparison with other brain neoplasia of grades I-III. Mol. Oncol. 2014, 8:417-430.
66. Visani M., de Biase D., Marucci G., Taccioli C., Baruzzi A., Pession A. Definition of miRNAs expression profile in glioblastoma samples: the relevance of non-neoplastic brain reference. PLoS One 2013, 8:e55314.
67. Vo N., Klein M.E., Varlamova O., Keller D.M., Yamamoto T., Goodman R.H., Impey S. A cAMP-response element binding protein-induced microRNA regulates neuronal morphogenesis. Proc. Natl. Acad. Sci. U S A 2005, 102:16426-16431.
68. Wang M., Li C., Nie H., Lv X., Qu Y., Yu B., Su L., Li J., Chen X., Ju J., Yu Y., Yan M., Gu Q., Zhu Z., Liu B. Down-regulated miR-625 suppresses invasion and metastasis of gastric cancer by targeting ILK. FEBS Lett. 2012, 586:2382-2388.
69. Yan H.L., Xue G., Mei Q., Wang Y.Z., Ding F.X., Liu M.F., Lu M.H., Tang Y., Yu H.Y., Sun S.H. Repression of the miR-17-92 cluster by p53 has an important function in hypoxia-induced apoptosis. EMBO J. 2009, 28:2719-2732.
70. Yan W., Li R., Liu Y., Yang P., Wang Z., Zhang C., Bao Z., Zhang W., You Y., Jiang T. MicroRNA expression patterns in the malignant progression of gliomas and a 5-microRNA signature for prognosis. Oncotarget 2014, 5:12908-12915.
71. Zhang B., Chen J., Ren Z., Chen Y., Li J., Miao X., Song Y., Zhao T., Li Y., Shi Y., Ren D., Liu J. A specific miRNA signature promotes radioresistance of human cervical cancer cells. Cancer Cell Int. 2013, 13:118.
72. Zhang Y., Dutta A., Abounader R. The role of microRNAs in glioma initiation and progression. Front. Biosci. 2012, 17:700-712.
73. Zhou J., Wang W., Gao Z., Peng X., Chen X., Chen W., Xu W., Xu H., Lin M.C., Jiang S. MicroRNA-155 promotes glioma cell proliferation via the regulation of MXI1. PLoS One 2013, 8:e83055.
74. Zhou Y., Hu Y., Yang M., Jat P., Li K., Lombardo Y., Xiong D., Coombes R.C., Raguz S., Yague E. The miR-106b~25 cluster promotes bypass of doxorubicin-induced senescence and increase in motility and invasion by targeting the E-cadherin transcriptional activator EP300. Cell Death Differ. 2014, 21:462-474.